000			02096nam a2200469 i 4500
999			_c289303 _d289303
001			on1123175518
003			OCoLC
005			20191206145805.0
006			m o d f
007			cr |||||||||||
008			191015s2019 dcua ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dGPO _dMvI
042			_apcc
043			_an-us---
074			_a1009-D-01 (online)
086	0		_aY 4.AG 4:S.HRG.115-670
088			_aSerial no. 115-14 (United States. Congress. Senate. Special Committee on Aging)
099			_aY 4.AG 4:S.HRG.115-670
110	1		_aUnited States. _bCongress. _bSenate. _bSpecial Committee on Aging,
245	1	0	_aFrom joint pain to pocket pain : _bcost and competition among rheumatoid arthritis therapies : hearing before the Special Committee on Aging, United States Senate, One Hundred Fifteenth Congress, second session, Washington, DC, February 7, 2018.
246	3	0	_aCost and competition among rheumatoid arthritis therapies
264		1	_aWashington : _bU.S. Government Publishing Office, _c2019.
300			_a1 online resource (iii, 54 pages) : _billustration.
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aS. hrg. ; _v115-670
500			_a"Serial no. 115-14."
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588			_aDescription based on online resource; title from PDF title screen (govinfo web site, viewed on Oct. 14, 2019).
776	0	8	_iPrint version: _aUnited States. Congress. Senate. Special Committee on Aging. _tFrom joint pain to pocket pain _w(OCoLC)1123175349
810	1		_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v115-670.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo127030
050		4	_aKF26.5 _b.A3 2018b
650		0	_aRheumatoid arthritis _xTreatment _zUnited States _xCosts.
650		0	_aDrugs _zUnited States _xCosts.
650		0	_aHealth insurance _zUnited States.
650		0	_aGeneric drugs _zUnited States.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8